apnea has been researched along with Obesity in 58 studies
Apnea: A transient absence of spontaneous respiration.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Excerpt | Relevance | Reference |
---|---|---|
"To determine if weight loss and/ or changes in apnea-hypopnea index (AHI) improve sleep architecture in overweight/ obese adults with type 2 diabetes (T2D) and obstructive sleep apnea (OSA)." | 9.19 | Sleep architecture following a weight loss intervention in overweight and obese patients with obstructive sleep apnea and type 2 diabetes: relationship to apnea-hypopnea index. ( Foster, GD; Jakicic, JM; Kuna, ST; Millman, RP; Newman, AB; Pi-Sunyer, FX; Reboussin, DM; RoyChoudhury, A; Shechter, A; St-Onge, MP; Wadden, TA; Wing, RR; Zammit, G, 2014) |
" In humans, after 8 minutes of apnea, Spo2 decreased below 90% while the worst value was 95% during the simulation." | 7.79 | What is the accuracy of the high-fidelity METI Human Patient Simulator physiological models during oxygen administration and apnea maneuvers? ( Asehnoune, K; Blondel, P; Brisard, L; Lejus, C; Magne, C; Péan, D, 2013) |
"3 who showed persistent apnea at emergence after ovarian resection." | 7.73 | [Persistent apnea in an obese patient with myotonic dystrophy]. ( Araki, E; Hashimoto, K; Koyama, Y; Nakahashi, Y; Takeda, K; Yamaguchi, K, 2005) |
"To compare anthropomorphic, nocturnal polysomnographic (PSG), and multiple sleep latency test (MSLT) data between positional (PP) and nonpositional (NPP) obstructive sleep apnea (OSA) patients." | 7.69 | Positional vs nonpositional obstructive sleep apnea patients: anthropomorphic, nocturnal polysomnographic, and multiple sleep latency test data. ( Arons, E; Oksenberg, A; Radwan, H; Silverberg, DS, 1997) |
"Obese patients have a decreased functional residual capacity and, hence, a reduced oxygen supply during periods of apnea." | 7.68 | Effect of obesity on safe duration of apnea in anesthetized humans. ( Dubin, SA; Jense, HG; O'Leary-Escolas, U; Silverstein, PI, 1991) |
"Six human obese subjects with the sleep apnea hypersomnolence syndrome associated with upper airway occlusion (UAO) were studied during sleep to characterize respiration." | 7.66 | Respiratory mechanics and timing during sleep in occlusive sleep apnea. ( Martin, RJ; Orr, WC; Pennock, BE; Rogers, RM; Sanders, MH, 1980) |
"Sleep apnea syndrome is a constellation of symptoms resulting from recurrent episodes of apnea during sleep." | 7.66 | Endoscopic findings in sleep apnea syndrome. ( Maisel, RH; Rybak, LP, 1979) |
"Periodic sleep apnea may be due to repeated episodes of upper airway obstruction in patients who have a short thick neck and/or large jowls." | 7.65 | Periodic sleep apnea: chronic sleep deprivation related to intermittent upper airway obstruction and central nervous system disturbance. ( Forrest, T; Greeneltch, D; Landa, J; Sackner, MA, 1975) |
" Excessive somnolence was due to the obesity, which during sleep caused airway obstruction, apnea, and awakening, finally resulting in sleep deprivation." | 7.65 | Sleep apnea in a child with the pickwickian syndrome. ( Rockenmacher, S; Rosenthal, A; Simpser, MD; Strieder, DJ; Wohl, ME, 1977) |
" Secondary outcomes included the lowest arterial oxygen content before intubation expressed in mm Hg, safe apnea time expressed in seconds, the lowest oxygen saturation before intubation expressed as a percentage, patient-reported discomfort, the need for rescue ventilation, and the incidence of aspiration of gastric contents during intubation." | 5.41 | High-Flow Nasal Cannula for Apneic Oxygenation in Obese Patients for Elective Surgery: A Systematic Review and Meta-Analysis. ( Bright, MR; Eley, V; Harley, WA; Velli, G; Zahir, SF, 2023) |
"All subjects had severe daytime somnolence, and five of the seven had congestive heart failure." | 5.26 | Progesterone therapy in obese patients with sleep apnea. ( Imes, NK; Martin, RJ; Orr, WC, 1979) |
"Clinically important prolongation of safe apnea times can be achieved delivering buccal oxygen to obese patients on induction of anesthesia." | 5.24 | Apneic Oxygenation During Prolonged Laryngoscopy in Obese Patients: A Randomized, Controlled Trial of Buccal RAE Tube Oxygen Administration. ( Aranda Palacios, AM; Evans, JR; Heard, A; Lauer, S; Toner, AJ, 2017) |
" We found that HFNO prolonged the safe apnea time at induction compared to control group [mean difference (MD) = 73." | 5.22 | Efficacy of high-flow nasal oxygenation against peri- and post-procedural hypoxemia in patients with obesity: a meta-analysis of randomized controlled trials. ( Chang, PC; Huang, PW; Hung, KC; Ko, CC; Lin, CH; Sun, CK; Teng, IC; Wang, KF, 2022) |
"To determine if weight loss and/ or changes in apnea-hypopnea index (AHI) improve sleep architecture in overweight/ obese adults with type 2 diabetes (T2D) and obstructive sleep apnea (OSA)." | 5.19 | Sleep architecture following a weight loss intervention in overweight and obese patients with obstructive sleep apnea and type 2 diabetes: relationship to apnea-hypopnea index. ( Foster, GD; Jakicic, JM; Kuna, ST; Millman, RP; Newman, AB; Pi-Sunyer, FX; Reboussin, DM; RoyChoudhury, A; Shechter, A; St-Onge, MP; Wadden, TA; Wing, RR; Zammit, G, 2014) |
"After thorough preoxygenation, and using total intravenous anesthesia, simulated difficult laryngoscopy was performed, with half the patients receiving additional nasal O(2) during apnea." | 5.14 | Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration. ( Cosnowski, A; Ramachandran, SK; Shanks, A; Turner, CR, 2010) |
"Preoxygenation increases oxygen reserves and duration of apnea without desaturation (DAWD), thus it provides valuable additional time to secure the airway." | 4.85 | Optimizing preoxygenation in adults. ( Donati, F; Drolet, P; Tanoubi, I, 2009) |
" First of all, some features of the so called metabolic syndrome; furthermore, hormonal alteration during and after puberty, genital appearance in the obese adolescent male, respiratory problems as apnea, asthma, and the Pickwick syndrome." | 4.84 | [Obesity in adolescents: physical correlated pathologies, and therapeutic state of art]. ( Giorgi, PL, 2007) |
" Snoring and sleep apnea were present before GH treatment, and did not increase during therapy." | 4.82 | Death during GH therapy in children with Prader-Willi syndrome: description of two new cases. ( Corrias, A; Crinò, A; Grugni, G; Livieri, C; Sartorio, A, 2005) |
" Although more controlled studies would be helpful, relatively clear-cut indications for the use of ventilatory stimulants exist for hypercapnic obesity-hypoventilation patients (medroxyprogesterone), myxedema (thyroid replacement), central apnea (acetazolamide), and periodic breathing in congestive heart failure (theophylline)." | 4.80 | Pharmacologic treatment of sleep-disordered breathing. ( Hudgel, DW; Thanakitcharu, S, 1998) |
" Patients with upper airway obstruction may also have sleep apneas and the sleep deprivation syndrome." | 4.75 | Diagnosis of obstruction of the upper and central airways. ( Anthonisen, N; Antic, R; Bode, F; Kryger, M, 1976) |
"Apnea is common after induction of anesthesia and may produce dangerous hypoxemia, particularly in obese subjects." | 3.91 | High oxygen fraction during airway opening is key to effective airway rescue in obese subjects. ( Alahmadi, H; Bates, DG; Das, A; Hardman, JG; Laviola, M; Niklas, C, 2019) |
" In humans, after 8 minutes of apnea, Spo2 decreased below 90% while the worst value was 95% during the simulation." | 3.79 | What is the accuracy of the high-fidelity METI Human Patient Simulator physiological models during oxygen administration and apnea maneuvers? ( Asehnoune, K; Blondel, P; Brisard, L; Lejus, C; Magne, C; Péan, D, 2013) |
" MSNA was recorded microneurographically from the peroneal nerve at supine rest and during apnea-induced sympathoexcitation." | 3.76 | Sympathetic function in human carriers of melanocortin-4 receptor gene mutations. ( Dodt, C; Hebebrand, J; Heutling, D; Hinney, A; Iwen, KA; Lehnert, H; Sayk, F; Scherag, S; Wellhoner, JP, 2010) |
"3 who showed persistent apnea at emergence after ovarian resection." | 3.73 | [Persistent apnea in an obese patient with myotonic dystrophy]. ( Araki, E; Hashimoto, K; Koyama, Y; Nakahashi, Y; Takeda, K; Yamaguchi, K, 2005) |
"The purpose of this study was to determine the facial characteristics of nonobese patients with obstructive sleep apnea (OSA)." | 3.70 | Cephalometric characteristics of nonobese patients with severe OSA. ( Ferguson, KA; Pae, EK, 1999) |
"To compare anthropomorphic, nocturnal polysomnographic (PSG), and multiple sleep latency test (MSLT) data between positional (PP) and nonpositional (NPP) obstructive sleep apnea (OSA) patients." | 3.69 | Positional vs nonpositional obstructive sleep apnea patients: anthropomorphic, nocturnal polysomnographic, and multiple sleep latency test data. ( Arons, E; Oksenberg, A; Radwan, H; Silverberg, DS, 1997) |
"Obese patients have a decreased functional residual capacity and, hence, a reduced oxygen supply during periods of apnea." | 3.68 | Effect of obesity on safe duration of apnea in anesthetized humans. ( Dubin, SA; Jense, HG; O'Leary-Escolas, U; Silverstein, PI, 1991) |
" Alveolar Po2 decreased to 70 mmHg in the obese group after just 15 s of apnea, whereas this degree of hypoxia did not occur in the nonobese until the breath hold was sustained for 30 s." | 3.67 | Voluntary breath holding in the obese. ( Hurewitz, AN; Sampson, MG, 1987) |
"Six human obese subjects with the sleep apnea hypersomnolence syndrome associated with upper airway occlusion (UAO) were studied during sleep to characterize respiration." | 3.66 | Respiratory mechanics and timing during sleep in occlusive sleep apnea. ( Martin, RJ; Orr, WC; Pennock, BE; Rogers, RM; Sanders, MH, 1980) |
"Normal subjects may present central-type apneas or periodic respiration during sleep (stages I and II and paradoxical sleep)." | 3.66 | Sleep respiratory arrhythmias in control subjects, narcoleptics and non-cataplectic hypersomniacs. ( Autret, A; Beillevaire, T; Castaigne, P; Cathala, HP; Laffont, F; Minz, M, 1978) |
" The two patients with the most frequent episodes of apnea and lowest oxygen saturation had a clinical picture consistent with the pickwickian syndrome." | 3.66 | Sleep-disordered breathing and oxygen desaturation in obese patients. ( Block, AJ; Harman, E; Malloy-Fisher, L; Wynne, JW, 1981) |
"When the syndrome consisting of sleep-induced apnea and hypersomnolence is due to upper airway obstruction, the hypersomnolence is believed to be the direct result of deprivation of sleep related to such obstructions." | 3.66 | Hypersomnolent and nonhypersomnolent patients with upper airway obstruction during sleep. ( Imes, NK; Martin, RJ; Orr, WC; Rogers, RM; Stahl, ML, 1979) |
"Sleep apnea syndrome is a constellation of symptoms resulting from recurrent episodes of apnea during sleep." | 3.66 | Endoscopic findings in sleep apnea syndrome. ( Maisel, RH; Rybak, LP, 1979) |
" Excessive somnolence was due to the obesity, which during sleep caused airway obstruction, apnea, and awakening, finally resulting in sleep deprivation." | 3.65 | Sleep apnea in a child with the pickwickian syndrome. ( Rockenmacher, S; Rosenthal, A; Simpser, MD; Strieder, DJ; Wohl, ME, 1977) |
"Periodic sleep apnea may be due to repeated episodes of upper airway obstruction in patients who have a short thick neck and/or large jowls." | 3.65 | Periodic sleep apnea: chronic sleep deprivation related to intermittent upper airway obstruction and central nervous system disturbance. ( Forrest, T; Greeneltch, D; Landa, J; Sackner, MA, 1975) |
"Obesity is an important public health problem worldwide and is a major risk factor for a number of chronic diseases such as type II diabetes, adverse cardiovascular events and metabolic syndrome-related features." | 2.48 | Usefulness of combining intermittent hypoxia and physical exercise in the treatment of obesity. ( González-Muniesa, P; Martínez, JA; Portillo, MP; Urdampilleta, A, 2012) |
" Long term use produces tolerance to some of the pharmacological effects." | 2.39 | Pharmacological rationale for the clinical use of caffeine. ( Sawynok, J, 1995) |
"Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) is gaining acceptance as a safe method for apneic ventilation and oxygenation during laryngeal procedures, but remains controversial during laser laryngeal surgery (LLS) due to the theoretical risk of airway fire." | 1.91 | Safety and Utility of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) for Laser Laryngeal Surgery. ( Damrose, EJ; Khan, NC; Nekhendzy, V; Saxena, A; Sung, CK; Vukkadala, N, 2023) |
"All subjects had severe daytime somnolence, and five of the seven had congestive heart failure." | 1.26 | Progesterone therapy in obese patients with sleep apnea. ( Imes, NK; Martin, RJ; Orr, WC, 1979) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 25 (43.10) | 18.7374 |
1990's | 7 (12.07) | 18.2507 |
2000's | 5 (8.62) | 29.6817 |
2010's | 16 (27.59) | 24.3611 |
2020's | 5 (8.62) | 2.80 |
Authors | Studies |
---|---|
Guy, L | 1 |
Christensen, R | 1 |
Dodd, B | 1 |
Pelecanos, A | 1 |
Wyssusek, K | 1 |
Van Zundert, A | 1 |
Eley, VA | 1 |
Hung, KC | 1 |
Ko, CC | 1 |
Chang, PC | 1 |
Wang, KF | 1 |
Teng, IC | 1 |
Lin, CH | 1 |
Huang, PW | 1 |
Sun, CK | 1 |
Bright, MR | 2 |
Harley, WA | 2 |
Velli, G | 2 |
Zahir, SF | 2 |
Eley, V | 2 |
Hung Tsan, S | 1 |
Viknaswaran, N | 1 |
Lau, J | 1 |
Cheong, C | 1 |
Wang, C | 1 |
Khan, NC | 1 |
Vukkadala, N | 1 |
Saxena, A | 1 |
Damrose, EJ | 1 |
Nekhendzy, V | 1 |
Sung, CK | 1 |
Laviola, M | 1 |
Niklas, C | 1 |
Alahmadi, H | 1 |
Das, A | 1 |
Bates, DG | 1 |
Hardman, JG | 1 |
Fei, M | 1 |
Blair, JL | 1 |
Rice, MJ | 1 |
Edwards, DA | 1 |
Liang, Y | 1 |
Pilla, MA | 1 |
Shotwell, MS | 1 |
Jiang, Y | 1 |
Makkar, JK | 1 |
Singh, NP | 1 |
Singh, PM | 1 |
Moon, TS | 1 |
Tai, K | 1 |
Kim, A | 1 |
Gonzales, MX | 1 |
Lu, R | 1 |
Pak, T | 1 |
Smith, K | 1 |
Chen, JL | 1 |
Minhajuddin, AT | 1 |
Nnamani, N | 1 |
Fox, PE | 1 |
Ogunnaike, B | 1 |
Spencer, DJ | 1 |
Kacker, A | 1 |
Lejus, C | 1 |
Magne, C | 1 |
Brisard, L | 1 |
Blondel, P | 1 |
Asehnoune, K | 1 |
Péan, D | 1 |
Islam, S | 1 |
Aleem, F | 1 |
Ormiston, IW | 1 |
Shechter, A | 1 |
St-Onge, MP | 1 |
Kuna, ST | 1 |
Zammit, G | 1 |
RoyChoudhury, A | 1 |
Newman, AB | 1 |
Millman, RP | 1 |
Reboussin, DM | 1 |
Wadden, TA | 1 |
Jakicic, JM | 1 |
Pi-Sunyer, FX | 1 |
Wing, RR | 1 |
Foster, GD | 1 |
Ungureanu, N | 1 |
Mendonca, C | 1 |
Khan, RM | 1 |
Haris, A | 1 |
Sharma, P | 1 |
Kaul, N | 1 |
Heard, A | 1 |
Toner, AJ | 1 |
Evans, JR | 1 |
Aranda Palacios, AM | 1 |
Lauer, S | 1 |
Schumann, R | 1 |
Kwater, AP | 1 |
Bonney, I | 1 |
Ladd, D | 1 |
Kim, J | 1 |
Gupta, A | 1 |
Gumbert, SD | 1 |
Pivalizza, EG | 1 |
Tanoubi, I | 1 |
Drolet, P | 1 |
Donati, F | 1 |
Sayk, F | 1 |
Heutling, D | 1 |
Dodt, C | 1 |
Iwen, KA | 1 |
Wellhoner, JP | 1 |
Scherag, S | 1 |
Hinney, A | 1 |
Hebebrand, J | 1 |
Lehnert, H | 1 |
Ramachandran, SK | 1 |
Cosnowski, A | 1 |
Shanks, A | 1 |
Turner, CR | 1 |
Escourrou, P | 1 |
Meslier, N | 1 |
Raffestin, B | 1 |
Clavel, R | 1 |
Gomes, J | 1 |
Hazouard, E | 1 |
Paquereau, J | 1 |
Simon, I | 1 |
Orvoen Frija, E | 1 |
Urdampilleta, A | 1 |
González-Muniesa, P | 1 |
Portillo, MP | 1 |
Martínez, JA | 1 |
DAWSON, GR | 1 |
WEG, JG | 1 |
CALVERLY, JR | 1 |
JOHNSON, C | 1 |
MCNICOL, MW | 1 |
PRIDE, NB | 1 |
Nakahashi, Y | 1 |
Hashimoto, K | 1 |
Araki, E | 1 |
Koyama, Y | 1 |
Yamaguchi, K | 1 |
Takeda, K | 1 |
Grugni, G | 1 |
Livieri, C | 1 |
Corrias, A | 1 |
Sartorio, A | 1 |
Crinò, A | 1 |
Altermatt, FR | 1 |
Muñoz, HR | 1 |
Delfino, AE | 1 |
Cortínez, LI | 1 |
Giorgi, PL | 1 |
Dowell, AR | 1 |
Sieker, HO | 1 |
Schwartzman, R | 1 |
Harman, E | 1 |
Wynne, JW | 1 |
Block, AJ | 1 |
Malloy-Fisher, L | 1 |
Martin, RJ | 3 |
Pennock, BE | 1 |
Orr, WC | 3 |
Sanders, MH | 1 |
Rogers, RM | 2 |
Sawynok, J | 1 |
Oksenberg, A | 1 |
Silverberg, DS | 1 |
Arons, E | 1 |
Radwan, H | 1 |
Hudgel, DW | 1 |
Thanakitcharu, S | 1 |
Rosenblatt, WH | 1 |
Murphy, M | 1 |
Pae, EK | 1 |
Ferguson, KA | 1 |
Laffont, F | 1 |
Autret, A | 1 |
Minz, M | 1 |
Beillevaire, T | 1 |
Cathala, HP | 1 |
Castaigne, P | 1 |
Imes, NK | 2 |
Stahl, ML | 1 |
Rybak, LP | 1 |
Maisel, RH | 1 |
Weitzman, ED | 1 |
Hoffmeister, JA | 1 |
Cabatingan, O | 1 |
McKee, A | 1 |
Remmers, JE | 1 |
deGroot, WJ | 1 |
Sauerland, EK | 1 |
Anch, AM | 1 |
Shaw, TR | 1 |
Corrall, RJ | 1 |
Craib, IA | 1 |
Kuban, K | 1 |
Kryger, M | 1 |
Bode, F | 1 |
Antic, R | 1 |
Anthonisen, N | 1 |
Simpser, MD | 1 |
Strieder, DJ | 1 |
Wohl, ME | 1 |
Rosenthal, A | 1 |
Rockenmacher, S | 1 |
Schweizer, W | 1 |
Sackner, MA | 1 |
Landa, J | 1 |
Forrest, T | 1 |
Greeneltch, D | 1 |
Kopelman, PG | 1 |
Elliott, MW | 1 |
Simonds, A | 1 |
Cramer, D | 1 |
Ward, S | 1 |
Wedzicha, JA | 1 |
Jense, HG | 1 |
Dubin, SA | 1 |
Silverstein, PI | 1 |
O'Leary-Escolas, U | 1 |
Hurewitz, AN | 1 |
Sampson, MG | 1 |
Laval, P | 1 |
Feliciano, JM | 1 |
Kleisbauer, JP | 1 |
Poirier, R | 1 |
Nevsímal, O | 1 |
Nevsímalová, S | 1 |
Oouredník, A | 1 |
Nelson, RA | 1 |
Miller, T | 1 |
Wulfsohn, NL | 1 |
Paramelle, B | 1 |
Cau, G | 1 |
Garrel, S | 1 |
Rachail, J | 1 |
Perret, J | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Comparison of Mask Ventilation Techniques in Patients Requiring General Anesthesia[NCT02580526] | 104 participants (Actual) | Interventional | 2015-09-30 | Completed | |||
Response of Respiratory and Hemodynamic Parameters to Positive End-Expiratory Pressure Titration for Mechanically Ventilated Obese Patients: A Randomized Clinical Trial[NCT05508997] | 60 participants (Actual) | Interventional | 2021-12-01 | Completed | |||
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)[NCT00194259] | 320 participants (Anticipated) | Observational | 2001-08-31 | Active, not recruiting | |||
Effect of High-flow Nasal Oxygenation on Safe Apnea Time in Children With Open Mouth[NCT04849520] | 38 participants (Actual) | Interventional | 2021-08-12 | Completed | |||
Airway Management Via the Retromolar Route Access - a Clinical Study[NCT01961817] | 100 participants (Actual) | Interventional | 2013-07-31 | Completed | |||
Self-Assembled Modified Macintosh Videolaryngoscope Versus McGrath Macintosh (MAC®) Videolaryngoscope: Which is Better?[NCT04850976] | 62 participants (Actual) | Interventional | 2020-06-01 | Completed | |||
EPO2-A: Evaluation of Different Pre-Oxygenation Condition in Morbid Obesity: Effect of Position and Positive Pressure Ventilation During General Anesthesia Induction[NCT02590406] | 50 participants (Actual) | Interventional | 2015-09-30 | Completed | |||
"A Less-rapid Sequence Anesthetic Induction/Intubation Sequence? Does Apneic Oxygenation by Means of an Oxygenating Laryngoscope Blade Prolong the Duration of Apnea Without Desaturation in Paralyzed Non-obese and Morbidly Obese Patients?"[NCT02943629] | 0 participants (Actual) | Interventional | 2016-11-30 | Withdrawn (stopped due to Lack of feasibility) | |||
Evaluation of Different Pre-Oxygenation Conditions in Morbid Obesity: Position and Ventilation Mode, in a Respiratory Physiology Laboratory, on Voluntary Subjects[NCT02121808] | 20 participants (Actual) | Interventional | 2014-04-30 | Completed | |||
PreOxygenation for Airway Management: High Flow Versus Conventional Preoxygenation Therapy[NCT03240614] | 150 participants (Anticipated) | Interventional | 2018-07-30 | Recruiting | |||
Effect of the Duration of Pre-oxygenation (3 Minutes vs 6 Minutes) on Apnea Tolerance in Obese Patients (BMI> 30 kg / m2) During the Induction of General Anesthesia[NCT04699435] | 200 participants (Anticipated) | Interventional | 2021-01-13 | Recruiting | |||
"Apnoeic Oxygenation by Nasal Cannula During Airway Management in Children Undergoing General Anaesthesia: A Pilot Randomised Controlled Trial"[NCT03271827] | 30 participants (Actual) | Interventional | 2016-01-31 | Completed | |||
Apneic Oxygenation Via Nasal Cannulae: 15 L/Min vs High-Flow[NCT02755389] | Phase 4 | 45 participants (Actual) | Interventional | 2016-09-30 | Completed | ||
Analysis of Face Mask Leak With Nasal Cannula in Noninvasive Positive Pressure Ventilation: A Randomized Crossover Trial[NCT02743936] | Phase 4 | 64 participants (Actual) | Interventional | 2016-04-30 | Completed | ||
Preoxygenation With Optiflow™, a High Flow Nasal Cannula (HFNC), is Superior to Preoxygenation With Facemask in Morbidly Obese Patients Undergoing General Anesthesia[NCT03009877] | 0 participants (Actual) | Interventional | 2018-07-31 | Withdrawn (stopped due to withdrawn prior to IRB approval) | |||
EmergeNcy Department Apneic Oxygenation Versus Usual Care During Rapid Sequence Intubation : A Randomized Controlled Trial (The ENDAO Trial)[NCT02737917] | 206 participants (Actual) | Interventional | 2016-05-31 | Completed | |||
Apneic Oxygenation With a Nasal Cannula in the Obese and Morbidly Obese Surgical Patient: A Randomized, Double-Blinded, Placebo-Controlled Trial[NCT03671837] | 135 participants (Actual) | Interventional | 2017-07-12 | Completed | |||
Apneic Oxygenation in the Pediatric Intensive Care Unit[NCT03374046] | 41 participants (Actual) | Interventional | 2017-12-23 | Completed | |||
Isolated and Combined Effect of a Low Carbohydrate Diet and Chronic Exercise Exposure to Hypoxia on Glycaemic Control and Cardiovascular Risk Factors in Patients With Type 2 Diabetes[NCT05094505] | 42 participants (Actual) | Interventional | 2021-10-01 | Completed | |||
Validity of a Vibrating Postural Device for the Treatment of Positional Obstructive Sleep Apnea (Postural)[NCT03336515] | 128 participants (Actual) | Interventional | 2015-09-01 | Completed | |||
The Evaluation of the Astral VAPS AutoEPAP Treatment Algorithm[NCT02683772] | Phase 3 | 42 participants (Actual) | Interventional | 2016-04-15 | Completed | ||
Efficiency of Preoxygenation in Obese Patients: Evaluation of Traditional Method Versus Pressure Assisted Preoxygenation.[NCT00673634] | 30 participants (Actual) | Interventional | 2008-03-31 | Completed | |||
Oxygen Reserve Index: Utility as Early Warning for Desaturation in Morbidly Obese Patients[NCT03021551] | 80 participants (Actual) | Interventional | 2016-09-15 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Evaluation of the maximum expired oxygen fraction obtained in the two groups (NCT02590406)
Timeframe: After 3 minutes of pre-oxygenation
Intervention | Maximum expired fraction of oxygen obtai (Mean) |
---|---|
Beach Chair (BC) and ZEEP | 0.89 |
Reverse Trendelenburg and NIPPV | 0.91 |
Evaluation of the minimal saturation obtained after the resumption of the ventilation (NCT02590406)
Timeframe: After the end of the Non-hypoxic apnea time
Intervention | percent (Mean) |
---|---|
Beach Chair (BC) and ZEEP | 83.6 |
Reverse Trendelenburg and NIPPV | 85.3 |
Change of Non-hypoxic apnea time in obese patient during a General Anesthesia induction, as a result of different pre-oxygenation position and ventilation mode; 1-Beach Chair and No positive pressure ventilation, 2-Reverse Trendelenburg and positive pressure ventilation and PEEP. End of measure time frame is 5 minutes after intubation (NCT02590406)
Timeframe: After a 3 minutes pre-oxygenation period
Intervention | seconds (Mean) |
---|---|
Beach Chair (BC) and ZEEP | 216.7 |
Reverse Trendelenburg and NIPPV | 258.2 |
(NCT02590406)
Timeframe: Evaluation of the time needed to the beginning of the ventilation to the moment where the saturation is 97%
Intervention | seconds (Mean) |
---|---|
Beach Chair (BC) and ZEEP | 88.4 |
Reverse Trendelenburg and NIPPV | 68 |
Evaluation of time needed to obtain an expired fraction of oxygen of > 0,9 in the two groups during the pre-oxygenation (NCT02590406)
Timeframe: During the pre-oxygenation period
Intervention | seconds (Mean) |
---|---|
Beach Chair (BC) and ZEEP | 145.3 |
Reverse Trendelenburg and NIPPV | 85.1 |
Change of functional residual capacity (FRC), in obese patient, as a result of different pre-oxygenation positions; 1- supine, 2-beach-chair, 3- reverse Trendelenburg, in two different ventilation modes : 1- spontaneous ventilation at tidal volume, 2- non-invasive positive pressure ventilation with inspiratory assistance. (NCT02121808)
Timeframe: After a 5 minutes pre-oxygenation period
Intervention | ml (Mean) |
---|---|
1. Supine + NIPPV | 2573 |
2. Supine + Tidal Volume Spontaneous Ventilation | 2145 |
3. Beach Chair (Back 25 Deg) + NIPPV | 2456 |
4. Beach Chair (Back 25 Deg) + Tidal Volume Spontaneous Ventil | 2219 |
5. Proclive (Global 25 Deg) + NIPPV | 2684 |
6. Proclive (Global 25 Deg) + Tidal Volume Spontaneous Ventila | 2282 |
Face mask leak as measured in liters per minute by the noninvasive positive pressure ventilation machine (NCT02743936)
Timeframe: 2 minutes after mask placement
Intervention | Liters per minute (Median) |
---|---|
NIPPV With Nasal Cannula | 0 |
NIPPV Without Nasal Cannula | 0 |
Discomfort scored on a 0-10 verbal numerical rating scale (0 = no discomfort, 10 = most discomfort imaginable) (NCT02743936)
Timeframe: After study completion (approximately 2 minutes after study start)
Intervention | Scores on verbal numerical rating scale (Median) |
---|---|
NIPPV With Nasal Cannula | 3 |
NIPPV Without Nasal Cannula | 1 |
the average oxygen saturation as measured by peripheral capillary oxygen saturation (SpO2) (NCT02737917)
Timeframe: within 2 minutes of confirmation of endotracheal tube placement
Intervention | Percent Saturation (SpO2) (Mean) |
---|---|
Apneic Oxygenation | 92 |
Usual Care | 93 |
To assess sleep-breathing parameters between groups using mean AHI (#events/hour) (NCT02683772)
Timeframe: Overnight, up 8 hrs on night 1 and 2
Intervention | events per hour (Mean) |
---|---|
iVAPS With AutoEPAP | 4.71 |
iVAPS With Manual EPAP | 7.84 |
To assess Sleep-breathing parameters between groups using mean PCO2 (mmHg) (NCT02683772)
Timeframe: Overnight, up 8 hrs on night 1 and 2
Intervention | milimeters of mercury (Mean) |
---|---|
iVAPS With AutoEPAP | 45.49 |
iVAPS With Manual EPAP | 45.38 |
To assess Sleep-breathing parameters between groups using mean SpO2 (%) (NCT02683772)
Timeframe: Overnight, up 8 hrs on night 1 and 2
Intervention | percentage of oxygen saturation (Mean) |
---|---|
iVAPS With AutoEPAP | 94.24 |
iVAPS With Manual EPAP | 94.53 |
Mean paired difference AutoEPAP-manual EPAP: Comparison of Oxygen Desaturation Index 4% (ODI4%) values between groups by using mean ODI4% (#events/hour). A cross-over analysis was generated to investigate the influence of a possible period effect on the primary endpoint, paired change in ODI4% between Auto and manual EPAP (NCT02683772)
Timeframe: Overnight, up to 8 hrs on nights 1 and 2
Intervention | events per hour (Mean) |
---|---|
iVAPS With AutoEPAP | 3.16 |
iVAPS With Manual EPAP | 7.61 |
To assess sleep efficacy between groups by using rapid eye movement sleep (REM) (% of total sleep time) (NCT02683772)
Timeframe: Overnight, up to 8 hrs on nights 1 and 2
Intervention | percentage of total sleep time (Mean) |
---|---|
iVAPS With AutoEPAP | 73.70 |
iVAPS With Manual EPAP | 73.89 |
Evaluate the clinical utility of the change in the oxygen reserve index as an early warning of impending arterial oxygen desaturation in Obese patients (30 < BMI < 40 kg m-2) and Normal BMI patients (19 < BMI < 25 kg m-2). (NCT03021551)
Timeframe: 1 year
Intervention | seconds (Number) | |
---|---|---|
Added warning time in Obese | Added warning time in Normal BMI | |
Rainbow Sensor | 46.5 | 87.0 |
11 reviews available for apnea and Obesity
Article | Year |
---|---|
Efficacy of high-flow nasal oxygenation against peri- and post-procedural hypoxemia in patients with obesity: a meta-analysis of randomized controlled trials.
Topics: Apnea; Humans; Hypoxia; Obesity; Oxygen Inhalation Therapy; Randomized Controlled Trials as Topic | 2022 |
High-Flow Nasal Cannula for Apneic Oxygenation in Obese Patients for Elective Surgery: A Systematic Review and Meta-Analysis.
Topics: Adult; Anesthesia, General; Apnea; Cannula; Humans; Intubation, Intratracheal; Obesity; Oxygen; Oxyg | 2023 |
High-Flow Nasal Cannula for Apneic Oxygenation in Obese Patients for Elective Surgery: A Systematic Review and Meta-Analysis.
Topics: Adult; Anesthesia, General; Apnea; Cannula; Humans; Intubation, Intratracheal; Obesity; Oxygen; Oxyg | 2023 |
High-Flow Nasal Cannula for Apneic Oxygenation in Obese Patients for Elective Surgery: A Systematic Review and Meta-Analysis.
Topics: Adult; Anesthesia, General; Apnea; Cannula; Humans; Intubation, Intratracheal; Obesity; Oxygen; Oxyg | 2023 |
High-Flow Nasal Cannula for Apneic Oxygenation in Obese Patients for Elective Surgery: A Systematic Review and Meta-Analysis.
Topics: Adult; Anesthesia, General; Apnea; Cannula; Humans; Intubation, Intratracheal; Obesity; Oxygen; Oxyg | 2023 |
Effectiveness of preoxygenation during endotracheal intubation in a head-elevated position: a systematic review and meta-analysis of randomized controlled trials.
Topics: Apnea; Humans; Hypoxia; Intubation, Intratracheal; Obesity; Oxygen; Patient Positioning; Randomized | 2022 |
Does weight loss affect the apnea/hypopnea index?
Topics: Apnea; Bariatric Surgery; Humans; Obesity; Polysomnography; Weight Loss | 2014 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Optimizing preoxygenation in adults.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Closed-Circuit; Apnea; Female; Humans; Hypoxia; Obesity; | 2009 |
Usefulness of combining intermittent hypoxia and physical exercise in the treatment of obesity.
Topics: Animals; Apnea; Exercise Therapy; Humans; Hypoxia; Insulin Resistance; Obesity | 2012 |
Death during GH therapy in children with Prader-Willi syndrome: description of two new cases.
Topics: Apnea; Child; Child, Preschool; Fatal Outcome; Female; Human Growth Hormone; Humans; Male; Obesity; | 2005 |
[Obesity in adolescents: physical correlated pathologies, and therapeutic state of art].
Topics: Adolescent; Adult; Age Factors; Apnea; Bariatric Surgery; Bariatrics; Body Mass Index; Cardiovascula | 2007 |
Pharmacological rationale for the clinical use of caffeine.
Topics: Animals; Apnea; Caffeine; Central Nervous System; Headache; Humans; Hypotension; Obesity; Pain; Phos | 1995 |
Pharmacologic treatment of sleep-disordered breathing.
Topics: Acetazolamide; Antihypertensive Agents; Apnea; Bronchodilator Agents; Diuretics; Dyspnea; Evidence-B | 1998 |
Diagnosis of obstruction of the upper and central airways.
Topics: Airway Obstruction; Airway Resistance; Apnea; Bronchiectasis; Diagnosis, Differential; Female; Force | 1976 |
8 trials available for apnea and Obesity
Article | Year |
---|---|
The effect of transnasal humidified rapid-insufflation ventilator exchange (THRIVE) versus nasal prongs on safe apnoea time in paralysed obese patients: a randomised controlled trial.
Topics: Adult; Apnea; Bariatric Surgery; Female; Humans; Insufflation; Male; Middle Aged; Obesity; Oxygen; O | 2022 |
Comparison of effectiveness of two commonly used two-handed mask ventilation techniques on unconscious apnoeic obese adults.
Topics: Adult; Aged; Aged, 80 and over; Airway Management; Airway Obstruction; Apnea; Body Mass Index; Cross | 2017 |
Apneic Oxygenation During Prolonged Laryngoscopy in Obese Patients: a Randomized, Double-Blinded, Controlled Trial of Nasal Cannula Oxygen Administration.
Topics: Adult; Anesthesia, General; Apnea; Biomarkers; Cannula; Double-Blind Method; Female; Humans; Laryngo | 2019 |
Sleep architecture following a weight loss intervention in overweight and obese patients with obstructive sleep apnea and type 2 diabetes: relationship to apnea-hypopnea index.
Topics: Adult; Aged; Anthropometry; Apnea; Body Mass Index; Diabetes Mellitus, Type 2; Diet, Reducing; Femal | 2014 |
Apneic Oxygenation During Prolonged Laryngoscopy in Obese Patients: A Randomized, Controlled Trial of Buccal RAE Tube Oxygen Administration.
Topics: Administration, Buccal; Adult; Aged; Aged, 80 and over; Airway Management; Apnea; Female; Humans; La | 2017 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.
Topics: Apnea; Humans; Laryngoscopy; Male; Middle Aged; Nasal Cavity; Obesity; Oxygen; Prospective Studies | 2010 |
Pre-oxygenation in the obese patient: effects of position on tolerance to apnoea.
Topics: Adult; Anesthesia, General; Anthropometry; Apnea; Carbon Dioxide; Female; Humans; Intraoperative Com | 2005 |
Pre-oxygenation in the obese patient: effects of position on tolerance to apnoea.
Topics: Adult; Anesthesia, General; Anthropometry; Apnea; Carbon Dioxide; Female; Humans; Intraoperative Com | 2005 |
Pre-oxygenation in the obese patient: effects of position on tolerance to apnoea.
Topics: Adult; Anesthesia, General; Anthropometry; Apnea; Carbon Dioxide; Female; Humans; Intraoperative Com | 2005 |
Pre-oxygenation in the obese patient: effects of position on tolerance to apnoea.
Topics: Adult; Anesthesia, General; Anthropometry; Apnea; Carbon Dioxide; Female; Humans; Intraoperative Com | 2005 |
Short-term use of fluoxetine in asymptomatic obese subjects with sleep-related hypoventilation.
Topics: Adult; Apnea; Double-Blind Method; Female; Fluoxetine; Humans; Hypoventilation; Male; Middle Aged; O | 1992 |
39 other studies available for apnea and Obesity
Article | Year |
---|---|
Safety and Utility of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) for Laser Laryngeal Surgery.
Topics: Apnea; Carbon Dioxide; Humans; Insufflation; Lasers; Obesity; Retrospective Studies | 2023 |
High oxygen fraction during airway opening is key to effective airway rescue in obese subjects.
Topics: Apnea; Body Mass Index; Humans; Obesity; Oxygen; Tidal Volume | 2019 |
Prolongation of Apnea Time in Obese Patients-Concerns With Rate of Rise of CO2.
Topics: Apnea; Carbon Dioxide; Humans; Obesity; Partial Pressure | 2017 |
What is the accuracy of the high-fidelity METI Human Patient Simulator physiological models during oxygen administration and apnea maneuvers?
Topics: Anesthesia, General; Apnea; Computer Simulation; Humans; Lung; Manikins; Obesity; Oxygen Inhalation | 2013 |
Does the Kushida morphometric model predict outcomes following maxillomandibular advancement surgery for obstructive sleep apnoea?
Topics: Adult; Algorithms; Apnea; Body Mass Index; Cephalometry; Cohort Studies; Craniofacial Abnormalities; | 2014 |
Oxygenation during difficult videolaryngoscopy.
Topics: Apnea; Humans; Laryngoscopy; Male; Obesity; Oxygen | 2015 |
Oxygenating patients during difficult videolaryngoscopy.
Topics: Apnea; Humans; Laryngoscopy; Male; Obesity; Oxygen | 2015 |
Respiratory volume monitoring in an obese surgical population and the prediction of postoperative respiratory depression by the STOP-bang OSA risk score.
Topics: Adult; Apnea; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; Monitoring, Physiolog | 2016 |
Sympathetic function in human carriers of melanocortin-4 receptor gene mutations.
Topics: Adolescent; Adult; Anthropometry; Apnea; Blood Pressure; Child; Female; Heart Rate; Hemodynamics; He | 2010 |
[Which clinical approach and which diagnostic procedures for obstructive sleep apnea syndrome?].
Topics: Apnea; Chronic Disease; Decision Trees; Diagnosis, Differential; Female; Humans; Male; Medical Histo | 2010 |
A CASE OF POST-OPERATIVE APNOEA RESPONDING TO INTRAVENOUS SODIUM BICARBONATE INFUSION.
Topics: Acidosis; Apnea; Atropine; Bicarbonates; Bis-Trimethylammonium Compounds; Gallamine Triethiodide; Hu | 1964 |
HYPOTHYROIDISM AND ALVEOLAR HYPOVENTILATION.
Topics: Apnea; Central Nervous System Stimulants; Drug Therapy; Humans; Hypothyroidism; Hypoventilation; Men | 1965 |
UNEXPLAINED UNDERVENTILATION OF THE LUNGS.
Topics: Apnea; Bronchitis; Cardiomegaly; Coma; Heart Diseases; Heart Failure; Humans; Lung Diseases; Obesity | 1965 |
[Persistent apnea in an obese patient with myotonic dystrophy].
Topics: Adult; Anesthesia Recovery Period; Anesthesia, Epidural; Anesthesia, General; Apnea; Female; Humans; | 2005 |
Atypical periodic respiration in an obese patient.
Topics: Adult; Alkalosis; Apnea; Carbon Dioxide; Humans; Hyperventilation; Hypoxia; Male; Obesity; Respirato | 1967 |
Sleep-disordered breathing and oxygen desaturation in obese patients.
Topics: Adult; Apnea; Carbon Dioxide; Electroencephalography; Female; Humans; Male; Obesity; Oxygen; Oxygen | 1981 |
Respiratory mechanics and timing during sleep in occlusive sleep apnea.
Topics: Adult; Apnea; Esophagus; Humans; Lung; Lung Compliance; Lung Diseases, Obstructive; Male; Middle Age | 1980 |
Positional vs nonpositional obstructive sleep apnea patients: anthropomorphic, nocturnal polysomnographic, and multiple sleep latency test data.
Topics: Adult; Age Factors; Analysis of Variance; Anthropometry; Apnea; Arousal; Body Height; Body Mass Inde | 1997 |
The intubating laryngeal mask: use of a new ventilating-intubating device in the emergency department.
Topics: Adult; Aged; Apnea; Emergency Service, Hospital; Humans; Laryngeal Masks; Male; Mandible; Obesity | 1999 |
Cephalometric characteristics of nonobese patients with severe OSA.
Topics: Adult; Analysis of Variance; Apnea; Body Mass Index; Cephalometry; Cohort Studies; Face; Facial Bone | 1999 |
Sleep respiratory arrhythmias in control subjects, narcoleptics and non-cataplectic hypersomniacs.
Topics: Adult; Apnea; Arrhythmias, Cardiac; Cataplexy; Disorders of Excessive Somnolence; Electroencephalogr | 1978 |
Progesterone therapy in obese patients with sleep apnea.
Topics: Adult; Airway Obstruction; Apnea; Blood Gas Analysis; Disorders of Excessive Somnolence; Humans; Mal | 1979 |
Hypersomnolent and nonhypersomnolent patients with upper airway obstruction during sleep.
Topics: Adult; Airway Obstruction; Apnea; Blood Pressure; Carbon Dioxide; Disorders of Excessive Somnolence; | 1979 |
Endoscopic findings in sleep apnea syndrome.
Topics: Adolescent; Adult; Apnea; Electromyography; Endoscopy; Female; Humans; Laryngoscopy; Male; Middle Ag | 1979 |
The syndrome of hypersomnia and sleep-induced apnea.
Topics: Adult; Airway Obstruction; Animals; Apnea; Arrhythmias, Cardiac; Disorders of Excessive Somnolence; | 1979 |
Sleep apnea treated by intestinal bypass.
Topics: Adult; Apnea; Humans; Intestines; Male; Obesity; Sleep Wake Disorders | 1978 |
Pathogenesis of upper airway occlusion during sleep.
Topics: Adult; Airway Obstruction; Apnea; Electromyography; Female; Humans; Male; Middle Aged; Muscles; Obes | 1978 |
Cardiac and respiratory standstill during sleep.
Topics: Apnea; Arrhythmias, Cardiac; Coronary Disease; Humans; Male; Middle Aged; Obesity; Sleep Wake Disord | 1978 |
Recurrent hypersomnia secondary to sleep apnea.
Topics: Airway Obstruction; Apnea; Disorders of Excessive Somnolence; Humans; Obesity; Obesity Hypoventilati | 1978 |
Sleep apnea in a child with the pickwickian syndrome.
Topics: Apnea; Child, Preschool; Female; Humans; Obesity; Obesity Hypoventilation Syndrome; Sleep | 1977 |
[Heart failure--appraisal of clinical diagnostic criteria (authors transl)].
Topics: Aged; Apnea; Blood Pressure; Cardiac Volume; Heart Failure; Humans; Jugular Veins; Middle Aged; Obes | 1976 |
Periodic sleep apnea: chronic sleep deprivation related to intermittent upper airway obstruction and central nervous system disturbance.
Topics: Adult; Aged; Airway Obstruction; Apnea; Brain; Depression; Electroencephalography; Female; Hostility | 1975 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Effect of obesity on safe duration of apnea in anesthetized humans.
Topics: Adult; Anesthesia; Apnea; Humans; Hypoxia; Middle Aged; Obesity; Obesity, Morbid; Risk; Thiopental | 1991 |
Voluntary breath holding in the obese.
Topics: Apnea; Functional Residual Capacity; Humans; Lung Volume Measurements; Mathematics; Middle Aged; Obe | 1987 |
[Periodic respiration].
Topics: Age Factors; Apnea; Carbon Dioxide; Central Nervous System Diseases; Cheyne-Stokes Respiration; Huma | 1973 |
[Sleep disorders and periodic respiration in obese subjects].
Topics: Adult; Apnea; Electromyography; Humans; Hypercapnia; Male; Middle Aged; Obesity; Periodicity; Respir | 1973 |
Apneic anesthesia for microlaryngeal surgery.
Topics: Anesthesia, Intravenous; Apnea; Carbon Dioxide; Humans; Hydrogen-Ion Concentration; Laryngoscopy; La | 1973 |
Succinylcholine dosage based on lean body mass.
Topics: Adolescent; Adult; Aged; Anesthesia, General; Apnea; Body Weight; Female; Halothane; Humans; Intubat | 1972 |
[The respiratory pauses of plethoric patients].
Topics: Adult; Aged; Apnea; Female; Humans; Male; Middle Aged; Obesity; Obesity Hypoventilation Syndrome; Re | 1970 |